WO2013031030A1 - Feuille cosmétique - Google Patents
Feuille cosmétique Download PDFInfo
- Publication number
- WO2013031030A1 WO2013031030A1 PCT/JP2011/070413 JP2011070413W WO2013031030A1 WO 2013031030 A1 WO2013031030 A1 WO 2013031030A1 JP 2011070413 W JP2011070413 W JP 2011070413W WO 2013031030 A1 WO2013031030 A1 WO 2013031030A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic sheet
- sheet according
- skin
- cosmetic
- cellulose
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 116
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 58
- 239000012736 aqueous medium Substances 0.000 claims abstract description 57
- 239000000758 substrate Substances 0.000 claims abstract description 43
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 27
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 15
- 229920002678 cellulose Polymers 0.000 claims description 56
- 239000001913 cellulose Substances 0.000 claims description 55
- 235000010443 alginic acid Nutrition 0.000 claims description 34
- 229920000615 alginic acid Polymers 0.000 claims description 34
- 229920001282 polysaccharide Polymers 0.000 claims description 21
- 239000005017 polysaccharide Substances 0.000 claims description 21
- 150000004804 polysaccharides Chemical class 0.000 claims description 21
- 244000005700 microbiome Species 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 239000004745 nonwoven fabric Substances 0.000 claims description 14
- 239000000783 alginic acid Substances 0.000 claims description 13
- 229960001126 alginic acid Drugs 0.000 claims description 13
- 150000004781 alginic acids Chemical group 0.000 claims description 13
- 210000001724 microfibril Anatomy 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 10
- 208000020154 Acnes Diseases 0.000 claims description 5
- 206010000496 acne Diseases 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- 239000002759 woven fabric Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 15
- 238000012423 maintenance Methods 0.000 abstract description 2
- 235000010980 cellulose Nutrition 0.000 description 27
- -1 polyethylene Polymers 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000010410 layer Substances 0.000 description 19
- 239000000499 gel Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 15
- 239000003349 gelling agent Substances 0.000 description 15
- 229940072056 alginate Drugs 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000004088 foaming agent Substances 0.000 description 12
- 150000001768 cations Chemical class 0.000 description 11
- 239000008406 cosmetic ingredient Substances 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 239000002562 thickening agent Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 5
- 239000008341 cosmetic lotion Substances 0.000 description 5
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 229920000136 polysorbate Polymers 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 241000589220 Acetobacter Species 0.000 description 4
- 241001474374 Blennius Species 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 229920003043 Cellulose fiber Polymers 0.000 description 4
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 4
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000235858 Acetobacter xylinum Species 0.000 description 3
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 241000589634 Xanthomonas Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000012510 hollow fiber Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000002985 plastic film Substances 0.000 description 3
- 229920006255 plastic film Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000015424 sodium Nutrition 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- ZGIGZINMAOQWLX-UHFFFAOYSA-N Farnesyl acetate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOC(C)=O ZGIGZINMAOQWLX-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 241000032681 Gluconacetobacter Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241001598113 Laminaria digitata Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000006177 alkyl benzyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229960000292 pectin Drugs 0.000 description 2
- 229920002643 polyglutamic acid Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000008417 skin turnover Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- QAQSNXHKHKONNS-UHFFFAOYSA-N 1-ethyl-2-hydroxy-4-methyl-6-oxopyridine-3-carboxamide Chemical compound CCN1C(O)=C(C(N)=O)C(C)=CC1=O QAQSNXHKHKONNS-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- JKTAIYGNOFSMCE-UHFFFAOYSA-N 2,3-di(nonyl)phenol Chemical compound CCCCCCCCCC1=CC=CC(O)=C1CCCCCCCCC JKTAIYGNOFSMCE-UHFFFAOYSA-N 0.000 description 1
- XSXWOBXNYNULJG-UHFFFAOYSA-N 2-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=CC=C1O XSXWOBXNYNULJG-UHFFFAOYSA-N 0.000 description 1
- SZBYVOSSTHEBFR-UHFFFAOYSA-N 2-(2-methyloctan-2-yl)phenol Chemical compound CCCCCCC(C)(C)C1=CC=CC=C1O SZBYVOSSTHEBFR-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-NCZFFCEISA-N 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\COC(C)=O ZGIGZINMAOQWLX-NCZFFCEISA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000199897 Alaria esculenta Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000004455 Fucus spiralis Species 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 241000589216 Komagataeibacter hansenii Species 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 241000296380 Laminaria hyperborea Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001512709 Lessonia <stramenopiles> Species 0.000 description 1
- 241001260563 Lessonia nigrescens Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- SXZWBNWTCVLZJN-NMIJJABPSA-N N-tricosanoylsphing-4-enine-1-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)[C@H](O)\C=C\CCCCCCCCCCCCC SXZWBNWTCVLZJN-NMIJJABPSA-N 0.000 description 1
- 241001602876 Nata Species 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 241000983746 Saccharina latissima Species 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- SFRPDSKECHTFQA-ONOWFSFQSA-N [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] propanoate Chemical compound CCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SFRPDSKECHTFQA-ONOWFSFQSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- XDFCIPNJCBUZJN-UHFFFAOYSA-N barium(2+) Chemical compound [Ba+2] XDFCIPNJCBUZJN-UHFFFAOYSA-N 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- JHECKPXUCKQCSH-UHFFFAOYSA-J calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;hydrate Chemical compound O.[Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O JHECKPXUCKQCSH-UHFFFAOYSA-J 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229910000009 copper(II) carbonate Inorganic materials 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- ODDZENUCCGSDGC-UHFFFAOYSA-N copper;n'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;gold(1+);tetracyanide Chemical compound [Cu+2].[Au+].[Au+].N#[C-].N#[C-].N#[C-].N#[C-].NCCNCCNCCNCCN ODDZENUCCGSDGC-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000011646 cupric carbonate Substances 0.000 description 1
- 235000019854 cupric carbonate Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940031098 ethanolamine Drugs 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229940007703 farnesyl acetate Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940025902 konjac mannan Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- GUQXQVVVMILANR-UHFFFAOYSA-N lithium;magnesium Chemical compound [Li+].[Mg+2] GUQXQVVVMILANR-UHFFFAOYSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940070720 stearalkonium Drugs 0.000 description 1
- 125000005502 stearalkonium group Chemical group 0.000 description 1
- 229940102548 stearalkonium hectorite Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 229940105956 tea-dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
- ZPEJZWGMHAKWNL-UHFFFAOYSA-L zinc;oxalate Chemical compound [Zn+2].[O-]C(=O)C([O-])=O ZPEJZWGMHAKWNL-UHFFFAOYSA-L 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
Definitions
- the present invention relates to a cosmetic sheet for the skin, the lips and the like, and a package including the cosmetic sheet, as well as a cosmetic process using the cosmetic sheet.
- C0 2 carbon dioxide
- C0 2 can improve blood flow, so that it can exert slimming effects.
- C0 2 can improve the relief pattern of the skin, make pores on the skin less noticeable, treat acnes and pimples on the skin, make the skin bright and/or white, and/or improve the skin conditions (e.g., by firming, elasticizing or tightening).
- JP-A-2000-319187 discloses a composition which can be used for slimming and comprises water, a thickening agent, and C0 2 bubbles. The composition is applied onto the skin for the transdermal provision of C0 2 .
- JP-B-3633930 discloses applying a first
- nonwoven fabric sheet including an acid and water onto the skin, and applying a second nonwoven sheet including a carbonate onto the first nonwoven fabric sheet to generate C0 2 of the non-bubble type.
- the nonwoven fabric sheets may be difficult to fit to the skin, in particular, uneven skin such as that of a face, and the lips. Furthermore, when a user is standing or sitting up, the adhesion power of the nonwoven fabric sheets to the skin or the lips may be insufficient, and they may slip down from the skin or the lips.
- JP-B-3633930 also discloses a laminated sheet in which the above second nonwoven fabric sheet is covered with a plastic film such as a polyethylene film through which C0 2 cannot penetrate.
- the laminated sheet including the second nonwoven fabric sheet covered with the plastic film is stiff and difficult to fit to the skin, in particular uneven skin such as that of a face.
- An objective of the present invention is to provide a cosmetic sheet which can well prevent or reduce the evaporation of C0 2 to the atmosphere, so that it can provide sufficient cosmetic effects due to a relatively high concentration of C0 2 for a long time .
- Another objective of the present invention is to provide a cosmetic sheet which can well fit to the skin, the lips and the like of a user, and therefore, it can be used easily, and can provide a comfortable feeling on use.
- a cosmetic sheet comprising:
- At least one substrate comprising at least one gel-forming material
- At least one aqueous medium comprising 200 ppm or more
- the pH of the aqueous medium may be 8.0 or less, preferably 7.0 or less, and more preferably 6.0 or less.
- the carbon dioxide may have been made to dissolve to the aqueous medium by contacting the aqueous medium with the carbon dioxide with a high pressure of from 0.1 to 1 MPa, preferably 0.1 to 0.8 MPa, and more preferably 0.1 to 0.5 MPa.
- the substrate may be in the form of a gel.
- the cosmetic sheet may not comprise any woven or nonwoven fabric.
- fabric here means an aggregate of normal cellulose fibers from plant origin. It is preferable that the normal cellulose fibers have a diameter of 500 nm or more, more
- fabric here includes not only normal textile but also paper.
- the gel-forming material be selected from polysaccharides .
- the polysaccharide be alginic acid or a salt thereof.
- the polysaccharide be cellulose produced by at least one microorganism.
- Each cellulose may preferably comprise cellulose microfibrils.
- the cellulose microfibril may have a diameter of 1 to 100 nm, preferably 2 to 50 nm, and more preferably 3 to 10 nm. It is preferable that the cellulose microfibrils form a network structure.
- the thickness of the substrate may be 0.01 mm to 5 mm, preferably 0.05 mm to 3 mm, and more preferably 0.1 mm to 2 mm.
- the substrate comprise at least a part of the aqueous medium.
- the present invention also relates to a cosmetic process for the treatment of the skin or the lips, comprising a step of applying onto the skin or the lips at least one cosmetic sheet according to the present invention.
- the treatment may be slimming
- the present invention also relates to a package comprising at least one cosmetic sheet according to the present invention.
- Fig. 1 is a front view of an example of a cosmetic sheet
- the cosmetic composition according to the present invention is characterized by comprising:
- At least one substrate comprising at least one gel-forming
- At least one aqueous medium comprising 200 ppm or more
- the invention can fit well to the skin, even if the skin is uneven or has a nonlinear relief, as well as the lips of a user. Therefore, it can be used easily, and can provide the user with a
- the cosmetic sheet according to the present invention can be composed of a single sheet, and does not need to be prepared by laminating a plurality of sheets with the use of an adhesive or a heat treatment. Therefore, the cosmetic sheet according to the present invention can be prepared easily. Even if the cosmetic sheet according to the present invention is composed of a single sheet, it can have a good C0 2 -sealing capability.
- the cosmetic sheet according to the present invention is flexible. Therefore, even if the cosmetic sheet according to the present invention is in the form of a laminated sheet, it can well fit to the skin of a user, even to uneven skin such as that of the face, or the lips of a user. Therefore, the cosmetic sheet according to the present invention can be used easily, and can provide a comfortable feeling on use.. In addition, the cosmetic sheet according to the present invention in the form of a laminated sheet can have a better C0 2 -sealing capability.
- the substrate according to the present invention comprises at least one gel-forming material.
- the term "substrate” here means a support of the cosmetic sheet, that the substrate can be composed of a single layer or a plurality of layers. It is preferable that the substrate is composed of a single layer. It is possible that 80 wt%, preferably 90 wt%, and more preferably 100 wt% of the solid content of the substrate be derived from gel-forming material (s)
- gel-forming material means any substance which can form a gel.
- a single type of gel-forming material or a combination of different types of gel forming materials may be used.
- the gel-forming material may be selected from any conventional substances which can form a gel.
- substances which can form a gel mention may be made of polysaccharides, polyvinyl alcohols, poly (meth) acrylic acids or derivatives thereof, polyacrylamides and derivatives thereof,
- polyvinylpyrrolidones and derivatives thereof polyvinylethers and derivatives thereof, and mixtures thereof.
- the gel-forming material is selected from polysaccharides .
- Polysaccharide is a carbohydrate in which two or more, preferably 10 or more, monosaccharides are linked via a glycoside bond.
- the polysaccharide used in the present invention may be a simple polysaccharide or a complex polysaccharide such as
- mucopolysaccharide A single type of polysaccharide may be used, or two or more types of polysaccharides may be used together.
- gel-forming polysaccharides examples include starch, glycogen, cellulose, chitin, agarose, carrageenan, heparin, hyaluronic acid, pectin, xyloglucan, alginic acid, agar, guar gum, gum Arabic, karaya gum, quince seed gum, konjac mannan, tamarind seed gum, tara gum, dextrin, gum tragacanth, locust bean gum, cardollan, xanthan gum, jellan gum, dextran, pullulan, and derivatives thereof.
- cellulose derivative ( s ) mention may be made of, carboxy- methyl cellulose, sodium carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxyethyl cellulose, hydroxyethyl cellulose, hydroxyethylethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, methyl cellulose, sodium methyl cellulose, microcrystalline cellulose, sodium cellulose sulfate, and mixtures thereof.
- Carboxymethyl cellulose is preferable.
- the cellulose derivative ( s ) may also be selected from alkyl celluloses. These polymers are obtained by grafting an alkyl residue onto one or more hydroxy groups of the cellulose polymer to form the hydroxyalkyl derivative. These alkyl residues may be selected from the following groups: stearyl, isostearyl, lauryl, myristyl, cetyl, isocetyl, cocoyl, palmityl, oleyl, linonyl, ricinolyl, behenyl, and mixtures thereof. These hydroxyalkyl cellulose derivatives may also be subjected to chemical
- the gel-forming polysaccharide is selected from alginic acid, cellulose, and derivatives thereof.
- alginate a salt of alginic acid
- glycol alginate a salt of glycol alginate
- Alginic acid which is isolated from seaweed, is a polyuronic acid made up of two uronic acids: D-mannuronic acid and L-guluronic acid. The ratio of mannuronic acid and guluronic acid varies with factors such as seaweed species, plant age, and part of the seaweed (e.g., stem, leaf).
- Alginic acid is substantially insoluble in water. However, it forms water-soluble salts with alkali metals, such as sodium, potassium, and, lithium; magnesium; ammonium; and the substituted ammonium cations derived from lower amines, such as methyl amine, ethanol amine, diethanol amine, and triethanol amine.
- the salts are soluble in aqueous media above pH 4, but are converted to alginic acid when the pH is lowered below about pH 4.
- a water- insoluble alginate is formed if certain polyvalent cations, especially calcium, barium, strontium, zinc, copper(+2), aluminum, and mixtures thereof are present in the medium at appropriate concentrations .
- Water insoluble alginate salts in which the principal cation is calcium, are found in the fronds and stems of seaweeds of the class Phaeophyceae, examples of which are Fucus vesiculosus,
- Alginate may be reacted with an alkylene oxide, such as ethylene oxide or propylene oxide, to form a glycol alginate.
- the glycol is bonded to the alginate through the carboxyl groups.
- an alginate is reacted with propylene oxide to form propylene glycol alginate (PGA) .
- PGA propylene glycol alginate
- the propylene glycol alginate has a degree of
- Suitable alginates have a weight-average molecular weight of about 20,000 Daltons to about 500,000 Daltons.
- the weight- average molecular weight is calculated by first determining the intrinsic viscosity, then using the Mark-Houwink Sakurada
- alginates for example alginates of different molecular weights and/or G content, may be used.
- bio- cellulose The cellulose produced by the microorganism may be called "bio- cellulose".
- a single type of bio-cellulose may be used for the present invention.
- two or more types of bio- celluloses may be used together for the present invention.
- any microbe can be used as long as it can produce bio-cellulose.
- a single type of microorganism may be used, or two or more types of microorganisms may be used together. It is preferable to use at least one microbial strain of the genus Acetobacter, the genus Agrobacterium, the genus Rhizobium, the genus Sarcina, the genus Pseudomonas, the genus Achromobacter, the genus Alcaligenes, the genus Aerobacter, the genus
- Acetobacter Xylinum among the genus Acetobacter is most preferable.
- the bio-cellulose can be produced by culturing at least one microorganism which can produce bio-cellulose, such as those listed above.
- the mode of culturing the microorganism is not limited.
- a static culture mode or a spinner culture mode may be employed.
- a microorganism which can produce bio-cellulose will be seeded on a culture medium and incubated at a temperature of, for example, from 10 to 40 °C, preferably from 25 to 40°C, and for a time period of, for example, from 1 to 60 days, preferably from 5 to 14 days.
- the cellulose produced by the microorganism will accumulate at the surface of the culture medium to form a cellulose membrane.
- the thickness of the cellulose membrane will increase as the culture of the microorganism proceeds.
- the cellulose membrane can be in the form of a sheet. It is preferable to employ the static culture mode, since the collection of the cellulose membrane or sheet is easy.
- the conditions for culturing the microorganism are not limited either.
- any type of culture medium can be used as long as it can increase the microorganism which can produce the bio-cellulose.
- the culture medium includes sources of carbon, nitrogen, and the like, as well as inorganic salts, amino acids, vitamins and the like. It is possible to use a culture medium including natural ingredients from plants such as grains (for example, rice and wheat), vegetables (for example, cabbage and onion), and fruits (for example, orange and
- the obtained bio-cellulose may have less odor, and the culture medium can be handled safely.
- a culture medium including semi- natural or non-natural ingredients such as purified or modified natural ingredients (e.g., purified sugars) or chemicals (e.g., synthesized sweetners).
- the pH of the culture medium can be adjusted depending on the type of the microorganism. It is possible that the pH of the culture medium is from 2 to 9.
- the pH of the culture medium is from 2.5 to 7, and more preferably 3 to 5, because the
- the bio-cellulose comprises cellulose microfibrils.
- cellulose microfibril has a diameter of 1 to 100 nm, preferably 2 to 50 nm, and more preferably 3 to 10 nm.
- microfibrils can form a network structure wherein microfibrils are entwined with each other. It is preferable that the network structure is dense, in view of the strength of the bio-cellulose.
- the cellulose fibers of a woven or non-woven cotton fabric sheet or even a paper sheet have a micron-order diameter such as 10 to 100 ⁇ .
- the cellulose microfibrils are very fine such that they have a nano-order diameter such as 2 to 100 nm. Therefore, the macroscopic appearance of bio-cellulose is not similar to that of a woven or non-woven cotton fabric sheet or a paper sheet. Rather, bio-cellulose appears like agar or gelatin. Therefore, in the field of foods, bio-cellulose is well-known as the material of "nata de coco".
- the bio-cellulose obtained just from a culture medium with water because the microorganism can be removed, and because it may include the ingredients in the culture medium or organic acids derived from the microorganism ( s ) in the culture medium.
- the bio-cellulose obtained from the genus Acetobacter may include acetic acid. Therefore, it is possible to treat the bio-cellulose with alkali such as a sodium hydroxide aqueous solution. After treating the bio- cellulose with alkali, for safety reasons, the bio-cellulose may be treated with acid in order to neutralize the pH.
- bio-cellulose it is also preferable to wash the bio-cellulose with water without treating it with acid until the pH of the water becomes to the neutral range.
- Bio-cellulose can contain water. Therefore, the cosmetic sheet according to the present invention can preferably contain water.
- the cosmetic sheet according to the present invention which includes water can also have moisturizing or hydrating effects for the skin and the lips by alleviating dryness and wrinkles thereon .
- bio-cellulose has a unique feeling on touch, such as a cool feeling.
- the cosmetic sheet according to the present invention can provide a comfortable feeling on use based on the unique feeling on touch based on the bio-cellulose.
- the cellulose produced by microorganism ( s ) is relatively strong.
- it has a high tensile strength as compared to other natural polymers such as polyglutamic acid. Accordingly, the cosmetic sheet according to the present
- invention may not be broken but kept adhered onto the skin even though the skin moves when, for example, exercising.
- the substrate used in the cosmetic sheet according to the present invention has no or substantially small carbon dioxide
- the cosmetic sheet according to the present invention can prevent or reduce the evaporation of C0 2 to the atmosphere, and can provide sufficient cosmetic effects due to a relatively high concentration of C0 2 .
- the substrate comprising at least one gel- forming material such as polysaccharide, in particular alginate or cellulose produced by microorganism ( s )
- the cosmetic sheet according to the present invention can suitably fit the skin, even the skin of a face, or the lips which has or have complicated surfaces and does or do not have a flat surface. Therefore, the cosmetic sheet according to the present invention can be used easily even when a user is standing or sitting up.
- the substrate is in the form of a gel, because the substrate can have more flexibility.
- the gel is more preferable that the substrate is in the form of a gel, because the substrate can have more flexibility.
- At least one gelling agent can be used to form a gel.
- a single type of gelling agent may be used, or two or more types of gelling agents may be used together.
- a gelling agent or agents can preferably be used.
- a gelling agent or agents may be added to a gel-forming
- polysaccharide such as alginate preferably dissolved or dispersed in an aqueous medium to form a gel.
- the gelling agent may comprise a polyvalent cation, typically a divalent and/or a trivalent cation, or a mixture of polyvalent cations capable of gelling the gel-forming polymer.
- Suitable polyvalent cations include, for example, calcium(2+), barium(2+), strontium(2+ ) , iron(2+ ), zinc (2+) , copper (2+ ) , and aluminum ( 3+) .
- Preferred cations are divalent metal cations, more preferably the calcium (2+) cation.
- a salt or combination of salts that provides the desired gelling polyvalent cation or mixture of polyvalent cations can be used as the gelling agent.
- the gelling agent may be insoluble in water, but releases an ion capable of forming a gel in an acidic
- gelling agent may be soluble in water but the ion capable of forming a gel is complexed and becomes available only under acidic conditions.
- useful gelling agents include salts, such as the following, their hydrates, and mixtures thereof: calcium carbonate, calcium disodium edetate, calcium oxalate, dicalcium phosphate, tricalcium phosphate, tricalcium citrate, strontium carbonate, barium carbonate, cupric carbonate, zinc carbonate, zinc oxalate, and zinc phosphate.
- Preferred gelling agents are those that also provide a buffering effect and/or consume acid when the polyvalent cation is released. These include for example, bicarbonates , carbonates, and
- a preferred gelling agent especially for alginate, pectin and carrageenan, is calcium
- Aluminum ions are useful for gelling glycol alginates, which typically do not gel with calcium ions.
- the gel may be foamed.
- at least one foaming agent can be used to foam the gel.
- a single type of foaming agent may be used, or two or more types of foaming agents may be used together.
- a foaming agent or agents can preferably be used.
- a foaming agent or agents may be added together with the gelling agent (s) to a gel-forming material, in particular a polysaccharide such as alginate, preferably dissolved or
- foaming agent may be a polymeric foaming agent, a surfactant, or a mixture thereof.
- Polymeric foaming agents such as surface active hydrocolloids
- surface active hydrocolloids include methyl cellulose, hydroxy propyl methyl cellulose (HPMC) , hydroxy propyl cellulose (HPC) , and hydroxy ethyl cellulose (HEC) .
- the polymeric foaming agent is preferably soluble in water so that a homogeneous gelled foam is produced.
- a preferred water soluble foaming agent is hydroxy propyl methyl cellulose.
- Hydroxy propyl methyl cellulose produces small bubbles that last until gelation occurs.
- Emulsifiers and Laughlin, U.S. Pat. No. 3,929,678, incorporated herein by reference.
- Nonionic surfactants are typically condensation products of a hydrophobic organic aliphatic or alkyl aromatic compound and hydrophilic ethylene oxide and/or propylene oxide.
- the length of the resulting polyether chain can be adjusted to achieve the desired balance between the hydrophobic and hydrophilic
- Nonionic surfactants include, for example,
- alkyl phenols containing from about 8 to 18 carbon atoms in a straight- or branched-chain alkyl group such as t- octyl phenol and t-nonyl phenol with about 5 to 30 moles of ethylene oxide, for example nonyl phenol condensed with about 9.5 moles of ethylene oxide, dinonyl phenol condensed with about 12 moles of ethylene oxide; ethoxylated and propoxylated alcohols, especially Cio-20 alcohols, with 2 to 100 moles of ethylene oxide and/or propylene oxide per mole of alcohol, especially
- ethoxylates of primary alcohols containing about 8 to 18 carbon atoms in a straight or branched chain configuration with about 5 to 30 moles of ethylene oxide for example, the ethoxylates of decyl alcohol, cetyl alcohol, lauryl alcohol, or myristyl
- polyoxyethylene sorbitan trioleate TWEEN® 85
- anionic surfactants are sodium stearate, sodium cetyl sulfate, sodium lauryl sulfate, ammonium lauryl sulfate,
- a preferred anionic surfactant is sodium lauryl sulfate (sodium dodecyl sulfate) .
- Cationic surfactants include, for example, quaternary ammonium salts, such as cetyl trimethylammonium bromide, lauryl trimethyl ammonium chloride, alkyl benzyl methyl ammonium chlorides, alkyl benzyl dimethyl ammonium bromides, cetyl pyridinium bromide, and halide salts of quaternized polyoxyethylalkylamines .
- quaternary ammonium salts such as cetyl trimethylammonium bromide, lauryl trimethyl ammonium chloride, alkyl benzyl methyl ammonium chlorides, alkyl benzyl dimethyl ammonium bromides, cetyl pyridinium bromide, and halide salts of quaternized polyoxyethylalkylamines .
- Zwitterionic or amphoteric surfactants can also be used.
- the substrate comprise water, preferably at least a part of the aqueous medium comprising dissolved C0 2 mentioned below.
- C0 2 can be provided gradually from the substrate so that the cosmetic effects due to the C0 2 can last for a long time.
- the thickness of the substrate may vary.
- the thickness of the substrate can be, for example, from 0.01 mm to 5 mm, preferably from 0.05 mm to 3.0 mm, and more preferably from 0.1 to 2.0 mm.
- the cosmetic sheet according to the present invention comprises at least one aqueous medium comprising 200 ppm or more,
- the cosmetic sheet according to the present invention can prevent the C0 2 from being evaporated into the air.
- the aqueous medium here means water or an aqueous solution including water and optionally at least one other ingredient such as a thickening agent and a cosmetic ingredient explained later.
- the content of water in the aqueous medium may be 50 to 100 wt%, preferably 60 to 95 wt%, and more preferably 70 to 90 wt%,
- the pH of the aqueous medium is 8.0 or less, preferably 7.0 or less, more preferably 6.0 or less, and further more preferably 5.0 or less. If the pH of the aqueous medium is 8.0 or less, C0 2 can be present in the aqueous medium mainly in the form of dissolved C0 2 without being transformed to a carbonate ion (C0 3 2 ⁇ ) or a bicarbonate ion (HC0 3 " ) . In order to improve blood flow, the use of C0 2 (not a carbonate ion or a bicarbonate ion) is preferable.
- Carbon dioxide can be dissolved to the aqueous medium by any method.
- the aqueous medium can be contacted with carbon dioxide gas with a high pressure of from 0.1 to 1 MPa, preferably 0.1 to 0.8 MPa, and more preferably 0.1 to 0.5 MPa.
- the dissolution of C0 2 in the aqueous medium be performed at 30°C or less, preferably 25°C or less, and more preferably 20°C or less.
- an aqueous medium can be charged in a pressure bottle, and then C0 2 gas with a high pressure can be introduced into the pressure bottle. It is preferable that the aqueous medium have already been deaerated before being charged into the pressure bottle.
- an autoclave may be used as the pressure bottle. If the viscosity of the aqueous medium is high, this
- embodiment is preferable. It is preferable to agitate the
- an aqueous medium and a high pressure C0 2 gas can be introduced into a static mixer under circulation. It is preferable that the aqueous medium have already been deaerated before going through the static mixer.
- an aqueous medium can be introduced into a hollow fiber module, and high pressure C0 2 can be provided to the hollow fiber module such that the C0 2 can penetrate into the aqueous medium via the wall of the hollow fiber. If the viscosity of the aqueous medium is low, this embodiment is preferable .
- dry ice may be put into an aqueous medium in a pressure bottle, and left for a while. It is preferable to agitate the aqueous medium.
- any conventional device such as a stirrer may be used.
- the aqueous medium can comprise at least one thickening agent.
- the type of thickening agent is not limited. A single thickening agent or a combination of two or more thickening agent may be used.
- the thickening agent mention may be made of silicas, notably hydrophobic; clays such as montmorillonite, modified clays such as bentones for example, stearalkonium bentonite, stearalkonium hectorite; and the like.
- the amount of thickening agent can range from 0.05 to 40 wt%, preferably from 0.5 to 20 wt%, and more preferably from 1 to 15 wt%, relative to the total weight of the aqueous medium.
- the aqueous medium can comprise at least one cosmetic ingredient.
- the cosmetic ingredient ( s ) may be water-soluble or liposoluble.
- the water-soluble cosmetic ingredient ( s ) may be chosen from the following compounds: ascorbic acid and its biologically- compatible salts, enzymes, antibiotics, tightening agents, a- hydroxy acids and their salts, hydroxylated polyacids, sucroses and their derivatives, urea, amino acids, oligopeptides, water- soluble plant extracts and yeast extracts, protein hydrolysates , hyaluronic acid, mucopolysaccharides, vitamins B 2 , B 6 , H, PP, panthenol, folic acid, salicylic acetyl acid, allantoin,
- the liposoluble cosmetic ingredient ( s ) may be chosen from the following compounds: d- -tocopherol , dl-a-tocopherol, 1-a- tocopherol, dl-a-tocopherol acetate, ascorbyl palmitate, vitamin F and glycerides of vitamin F, vitamin D, vitamin D 2 , vitamin D 3 , retinol, retinol esters, retinol palmitate, retinol propionate, ⁇ -carotene, d-panthenol, farnesol, and farnesyl acetate;
- keratolytics such as salicylic acid, its salts and its esters, n- octanoyl-5 salicylic acid and its esters, a-hydroxyacid
- alkylesters such as citric acid, lactic acid, glycolic acid, asiatic acid, madecassic acid, asiaticoside, total extract of centella asiatica, ⁇ -glycyerrhetinic acid, a-bisabolol, and ceramides such as 2 oleoylamino-1, 3 octadecane, phytanetriol, milk sphingomyelin, phospholipids of marine origin rich in polyunsaturated essential fatty acids, and ethoxyquin, rosemary extract, melissa extract, quercetin, extract of dried microalgae, and steroid anti-inflammatory agents.
- citric acid lactic acid, glycolic acid, asiatic acid, madecassic acid, asiaticoside, total extract of centella asiatica, ⁇ -glycyerrhetinic acid, a-bisabolol, and ceramides such as 2 oleoylamino-1, 3
- the aqueous medium may comprise additional cosmetic active ingredients which are commonly used in cosmetics.
- additional cosmetic active ingredients which are commonly used in cosmetics.
- cosmetic active ingredients to be used mention may be made of anti-oxidant cleansing agents, free radical scavengers,
- moisturizers depigmenting agents, liporegulators, anti-acne agents, antidandruff agents, anti-aging agents, softeners, antiwrinkle agents, keratolytic agents, anti-inflammatory agents, fresheners, healing agents, vascular protectors, antibacterial agents, antifungal agents, antiperspirants, deodorants, skin conditioners, anesthetics, immunomodulators, nourishing agents, and sebum absorbers (e.g. Orgasol) or moisture absorbers.
- moisturizers e.g. Orgasol
- the amount of the cosmetic ingredient agent or the additional cosmetic active ingredient can range from 0.01 to 50 wt%,
- aqueous medium preferably from 0.1 to 30 wt%, and more preferably from 1 to 10 wt%, relative to the total weight of the aqueous medium.
- the cosmetic sheet according to the present invention can be prepared by combining the above substrate and the above aqueous medium.
- the substrate can be immersed in the aqueous medium in order for the substrate to absorb at least a part of the aqueous medium. If the viscosity of the aqueous medium is high, the cosmetic sheet can be prepared by applying the aqueous medium onto the substrate.
- the cosmetic sheet according to the present invention may preferably be used for cosmetically treating the face skin or the lips, it is preferable that the shape of the cosmetic sheet according to the present invention is such that it can cover the face or the lips of a user . Since the face is symmetric in terms of the center longitudinal axis of the face, it is preferable for the shape of the cosmetic sheet according to the present invention have C 2v symmetry such as a general oval shape.
- Fig. 1 shows a front view of an example of a cosmetic sheet according to the present invention.
- the cosmetic sheet shown in Figure 1 is intended to be applied onto the face, and is formed by a single substrate sheet (1) having holes (2,2) for the eyes, a hole (3) for the nose, and a hole (4) for the mouth. Any of the holes (2,2,3,4) may be replaced with slit(s) to uncover the eyes, nose and/or mouth.
- the substrate sheet (1) may have a tab or tabs, preferably on the outline thereof, for facilitating the handling of the cosmetic sheet.
- the dotted and dashed line (C) in Figure 1 corresponds to a longitudinal center line of the substrate sheet (1).
- longitudinal center line (C) shown in Figure 1 defines a center line of the substrate sheet (1) and is positioned to pass over the hole (3) for the nose as well as the hole (4) for the mouth.
- the longitudinal center line (C) shown in Figure 1 functions as a longitudinal symmetric axis for the substrate sheet (1) .
- the cosmetic sheet shown in Figure 1 can be applied to the face to cover the skin such that the aqueous medium can contact the skin .
- the cosmetic sheet according to the present invention may be used for any part of the body such as legs or waist. In such a case, the shape of the cosmetic sheet according to the present
- the cosmetic sheet according to the present invention may consist of a substrate, or may comprise the substrate and one or more additional layers thereon.
- the substrate may contain the above cosmetic ingredient ( s) .
- the cosmetic sheet according to the present invention comprises at least one additional layer in addition to the substrate, the additional layer and/or the substrate may contain the above cosmetic ingredient (s) .
- the material of the additional layer (s) is not limited, and therefore any material can be used for preparing the additional layer (s). Two or more different materials may be used.
- the material of the additional layer (s) may be a woven or non- woven fabric made of natural fibers such as cotton, pulp, bamboo and paper cellulose fibers, semi-natural fibers such as viscose rayon fibers and synthetic fibers such as polyester fibers, polyethylene terephthalate fibers, polyethylene fibers, and polypropylene fibers. Two or more selected from the above fibers may be used in combination.
- the material of the additional layer (s) may be a film or sheet made from at least one selected from synthetic polymers such as polyethylenes and polyvinylalcohols , semisynthetic polymers such as alginates, and natural polymers such as polypeptides (e.g., ⁇ -polyglutamic acid) and proteins (e.g., gelatin and collagen) .
- the film or sheet may be in the form of a gel or a jelly which may be transparent, translucent or opaque. Two or more selected from the above substances may be used in combination .
- each additional layer may be the same or different from each other.
- the additional layers may be prepared by laminating the above film or sheet made from a synthetic polymer, a semisynthetic polymer and/or a natural polymer on the above woven or non-woven fabric.
- the thickness of the additional layer is not limited.
- the thickness of the additional layer can be, for example, from 1 nm to 2.0 mm, preferably from 10 nm to 1.0 mm, and more preferably from 100 nm to 0.5 mm.
- the cosmetic sheet according to the present invention with the above additional layer (s) can be prepared by, for example, applying a gel-forming material onto the additional layer (s), or applying the additional layer (s) onto a gel forming material.
- the cosmetic sheet according to the present invention with the above additional layer(s) can be prepared by, for example, culturing microorganism to produce the bi-cellulose on the additional layer (s) .
- the cosmetic sheet according to the present invention is preferably composed of only a substrate, because it is easy to prepare the cosmetic sheet, and the flexibility of the cosmetic sheet will be enhanced. Accordingly, for example, the cosmetic sheet according to the present invention may not comprise any woven or nonwoven fabric.
- the cosmetic sheet according to the present invention may be contained in a container to prepare a package.
- the container may preferably be a bag or sack made from any material, preferably a plastic or metal film.
- the present invention relates to a package comprising the cosmetic sheet according to the present invention. If necessary, the cosmetic sheet according to the present invention may be folded.
- the above package comprising the cosmetic sheet according to the present invention further contains a cosmetic composition, preferably in the form of a liquid,
- the cosmetic sheet according to the present invention can be used for a cosmetic process for beautifying the skin or the lips.
- the cosmetic process according to the present invention is intended for treating the skin, preferably the skin of the face, or the lips, comprising a step of applying onto the skin or the lips at least one cosmetic sheet according to the present
- the cosmetic process according to the present invention can preferably be intended for slimming, improving the relief pattern of the skin, making pores on the skin less noticeable, treating acnes and pimples on the skin, making the skin bright and/or white, and/or improving the skin conditions.
- the cosmetic sheet according to the present invention may be applied onto the skin of the body and/or the face, and/or the lips of a user . It has been known that C0 2 has effects of accelerating blood flow by the vasodilatation of blood vessels, which contribute to slimming and activating the skin such as increasing skin turnover.
- C0 2 in blood will increase free 0 2 due to the Bohr effect (C0 2 encompassed in red blood cells cause with water to produce HC0 3 - and H+, so that the pH in the red blood cells is reduced, which results in the low affinity of the hemoglobin in the blood red cells with oxygen) .
- the free oxygen (0 2 ) can contribute to inactivate bacteria or the like, and can provide healing or treating effects.
- the carbon dioxide in the cosmetic sheet according to the present invention can have
- a substrate comprising at least one gel- forming polysaccharide such as bio-cellulose and/or alginic acid or a salt thereof, and preferably water, it can be especially easily or simply used by being applied onto the skin, preferably the skin of the face, or the lips.
- aqueous medium in the cosmetic sheet according to the present invention comprises at least one cosmetic ingredient, or if the cosmetic sheet according to the present invention
- the cosmetic process can be simplified, because a step of applying at least one cosmetic product onto the skin or the lips may be omitted.
- the cosmetic sheet according to the present invention it is possible to leave the cosmetic sheet according to the present invention on the skin or the lips for from 1 minute to 60 minutes, preferably from 10 minutes to 45 minutes, and more preferably from 15 minutes to 30 minutes.
- the cosmetic sheet according to the present invention comprises water
- the cosmetic sheet according to the present invention can also ameliorate wrinkles, in particular, not only fine lines but also deep lines such as nasolabial folds, and dryness of the skin or the lips.
- a high pressure (0.2 MPa) gas of C0 2 was provided from a C0 2 gas high pressure tank into a pressure bottle including an aqueous solution under agitation to dissolve the C0 2 gas into the aqueous solution.
- a cosmetic lotion including dissolved C0 2 was prepared.
- the concentration of C0 2 in the cosmetic lotion was 1,580 ppm.
- each of the following sheets was immersed in the above cosmetic lotion in order for each sheet to absorb the cosmetic lotion.
- Comparative Example 1 Spunlace nonwoven sheet (rayon fiber 45% and pulp fiber 55%) with a basis weight of 80 g/m 2
- Comparative Example 1 with a cosmetic lotion including C0 2 were prepared.
- test sheet according to Example 1 has lower air permeability so that it can better hold C0 2 as compared to the test sheet according to Comparative Example 1.
- test sheet according to Example 1 is applied onto half of the face of a female panelist, while the test sheet according to
- Comparative Example 1 is applied onto the other half of the face of the female panelist. Both test sheets are left for 10 minutes. Then, both test sheets are removed from the face.
- the blood flow on the face is measured with a laser doppler blood flow rate measurement device (Integral Corporation). It is found that the blood flow on the half of the face to which the test sheet according to Example 1 is applied is higher than that on the other half of the face to which the test sheet according to Comparative Example 1 is applied.
- test sheet according to Example 1 can provide better cosmetic effects derived from C0 2 gas such as slimming and skin turnover than the test sheet according to Comparative
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne une feuille cosmétique qui comprend: au moins un substrat comprenant au moins un matériau gélifiant; et au moins un support aqueux comprenant 200 ppm ou plus, de préférence 1000 ppm ou plus, et préférablement 1500 ppm ou plus, de dioxyde de carbone dissout dans le milieu aqueux. La feuille cosmétique de l'invention peut offrir des effets cosmétiques suffisants grâce au maintien d'une concentration relativement élevée de CO2 durant une longue période, et peut bien s'ajuster à la peau, aux lèvres et analogue de l'utilisateur, c'est pourquoi elle peut être aisément utilisée, et permet de fournir une sensation de confort lors de son utilisation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2011/070413 WO2013031030A1 (fr) | 2011-09-01 | 2011-09-01 | Feuille cosmétique |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2011/070413 WO2013031030A1 (fr) | 2011-09-01 | 2011-09-01 | Feuille cosmétique |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013031030A1 true WO2013031030A1 (fr) | 2013-03-07 |
Family
ID=44759741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/070413 WO2013031030A1 (fr) | 2011-09-01 | 2011-09-01 | Feuille cosmétique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013031030A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3081209A1 (fr) | 2015-04-13 | 2016-10-19 | Borregaard AS | Compositions de soins pour la peau contenant de la cellulose microfibrillée |
EP3081208A1 (fr) | 2015-04-13 | 2016-10-19 | Borregaard AS | Compositions de pulvérisation pour soins de la peau contenant de la cellulose microfibrillée |
EP3739119A4 (fr) * | 2018-01-10 | 2021-11-03 | Oji Holdings Corporation | Feuille |
IT202000017485A1 (it) | 2020-07-17 | 2022-01-17 | Davines S P A | Formulazioni cosmetiche per il trattamento di capelli con migliorate proprietà |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2036934A (en) | 1934-04-21 | 1936-04-07 | Kelco Co | Process for making alginic acid and product |
US2128551A (en) | 1934-01-11 | 1938-08-30 | Algin Corp Of America | Method of treating seaweed |
US2426125A (en) | 1944-04-03 | 1947-08-19 | Kelco Co | Manufacture of glycol alginates |
US3772266A (en) | 1972-10-19 | 1973-11-13 | Kelco Co | Process for the preparation of propylene glycol alginate from partially neutralized alginic acid |
US3929678A (en) | 1974-08-01 | 1975-12-30 | Procter & Gamble | Detergent composition having enhanced particulate soil removal performance |
US3948881A (en) | 1974-07-16 | 1976-04-06 | Uniroyal, Ltd. | Process for the production of alkylene glycol alginates |
JP2000319187A (ja) | 1999-05-06 | 2000-11-21 | Medion Research Laboratories Inc | 二酸化炭素経皮・経粘膜吸収用組成物 |
US6334968B1 (en) | 1996-05-22 | 2002-01-01 | Ben Gurion University Of The Negev | Method of forming polysaccharide sponges for cell culture and transplantation |
JP3633930B2 (ja) | 2002-07-05 | 2005-03-30 | ネオケミア株式会社 | 二酸化炭素外用剤及び二酸化炭素外用剤調製用材料 |
JP2005314379A (ja) * | 2004-03-30 | 2005-11-10 | Hiromaito Co Ltd | 化粧用パック剤及びその使用方法 |
US20060257504A1 (en) * | 2003-08-19 | 2006-11-16 | Neochemir Inc. | Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
JP2007230139A (ja) * | 2006-03-02 | 2007-09-13 | Japan Absorbent Technology Institute | 高通気性耐水性シート及びこれを有する吸収体物品 |
EP1849472A1 (fr) * | 2005-01-28 | 2007-10-31 | Neochemir Inc. | Composition pour preparer une preparation de dioxyde de carbone a usage externe |
JP2008069112A (ja) * | 2006-09-14 | 2008-03-27 | Toyo Shinyaku:Kk | パック用化粧品 |
-
2011
- 2011-09-01 WO PCT/JP2011/070413 patent/WO2013031030A1/fr active Application Filing
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2128551A (en) | 1934-01-11 | 1938-08-30 | Algin Corp Of America | Method of treating seaweed |
US2036934A (en) | 1934-04-21 | 1936-04-07 | Kelco Co | Process for making alginic acid and product |
US2426125A (en) | 1944-04-03 | 1947-08-19 | Kelco Co | Manufacture of glycol alginates |
US3772266A (en) | 1972-10-19 | 1973-11-13 | Kelco Co | Process for the preparation of propylene glycol alginate from partially neutralized alginic acid |
US3948881A (en) | 1974-07-16 | 1976-04-06 | Uniroyal, Ltd. | Process for the production of alkylene glycol alginates |
US3929678A (en) | 1974-08-01 | 1975-12-30 | Procter & Gamble | Detergent composition having enhanced particulate soil removal performance |
US6334968B1 (en) | 1996-05-22 | 2002-01-01 | Ben Gurion University Of The Negev | Method of forming polysaccharide sponges for cell culture and transplantation |
JP2000319187A (ja) | 1999-05-06 | 2000-11-21 | Medion Research Laboratories Inc | 二酸化炭素経皮・経粘膜吸収用組成物 |
JP3633930B2 (ja) | 2002-07-05 | 2005-03-30 | ネオケミア株式会社 | 二酸化炭素外用剤及び二酸化炭素外用剤調製用材料 |
US20060165607A1 (en) * | 2002-07-05 | 2006-07-27 | Masaya Tanaka | Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
US20060257504A1 (en) * | 2003-08-19 | 2006-11-16 | Neochemir Inc. | Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
JP2005314379A (ja) * | 2004-03-30 | 2005-11-10 | Hiromaito Co Ltd | 化粧用パック剤及びその使用方法 |
EP1849472A1 (fr) * | 2005-01-28 | 2007-10-31 | Neochemir Inc. | Composition pour preparer une preparation de dioxyde de carbone a usage externe |
JP2007230139A (ja) * | 2006-03-02 | 2007-09-13 | Japan Absorbent Technology Institute | 高通気性耐水性シート及びこれを有する吸収体物品 |
JP2008069112A (ja) * | 2006-09-14 | 2008-03-27 | Toyo Shinyaku:Kk | パック用化粧品 |
Non-Patent Citations (1)
Title |
---|
MARTINSEN ET AL.: "Comparison of Different Methods for Determination of Molecular Weights and Molecular Weight Distribution of Alginates", CARBOHYDR. POLYM., vol. 15, 1991, pages 171 - 193, XP024147014, DOI: doi:10.1016/0144-8617(91)90031-7 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3081209A1 (fr) | 2015-04-13 | 2016-10-19 | Borregaard AS | Compositions de soins pour la peau contenant de la cellulose microfibrillée |
EP3081208A1 (fr) | 2015-04-13 | 2016-10-19 | Borregaard AS | Compositions de pulvérisation pour soins de la peau contenant de la cellulose microfibrillée |
WO2016166179A1 (fr) * | 2015-04-13 | 2016-10-20 | Borregaard As | Compositions pour soins de la peau comprenant de la cellulose microfibrillée |
CN107645950A (zh) * | 2015-04-13 | 2018-01-30 | 宝利格股份有限公司 | 包含微原纤化纤维素的皮肤护理组合物 |
CN107645950B (zh) * | 2015-04-13 | 2021-04-20 | 宝利格股份有限公司 | 包含微原纤化纤维素的皮肤护理组合物 |
EP3739119A4 (fr) * | 2018-01-10 | 2021-11-03 | Oji Holdings Corporation | Feuille |
IT202000017485A1 (it) | 2020-07-17 | 2022-01-17 | Davines S P A | Formulazioni cosmetiche per il trattamento di capelli con migliorate proprietà |
WO2022013900A1 (fr) | 2020-07-17 | 2022-01-20 | Davines S.P.A. | Formulations cosmétiques pour le traitement capillaire ayant des propriétés améliorées |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008266060B2 (en) | Alginate coated, polysaccharide gel-containing foam composite, preparative methods, and uses thereof | |
US8450294B2 (en) | Shampoo compositions | |
US20090318571A1 (en) | Hydrocolloids and Process Therefor | |
WO2003068824A1 (fr) | Derives de membranes cellulaires provenant de la biomasse et leur preparation | |
WO2006065469A1 (fr) | Procede de preparation d’hydrocolloides | |
CN102212208A (zh) | 细菌纤维素/透明质酸复合材料的制备方法 | |
WO2020001069A1 (fr) | Kit de soins de la peau | |
WO2006062792A2 (fr) | Hydrocolloides et procede associe | |
CN113226248B (zh) | 用于护理皮肤的套装 | |
WO2019047954A1 (fr) | Kit de soin de la peau | |
CN115192473B (zh) | 用于护理皮肤的套装 | |
JP2008137970A (ja) | 生体用粘着ゲルシートおよびそれを用いたシート状化粧料 | |
WO2013031030A1 (fr) | Feuille cosmétique | |
US20150038458A1 (en) | Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof | |
KR20160146259A (ko) | 바이오 셀룰로오스를 포함하는 하이드로겔의 제조방법 | |
CN113194906B (zh) | 用于皮肤护理的试剂盒 | |
CN109577003A (zh) | 海藻纤维面膜基布及其制备方法 | |
CN108578352A (zh) | 一种温感型面膜的制备方法 | |
JP2008285461A (ja) | 生体用粘着ゲルシートおよびそれを含むシート状化粧料 | |
CN113194921A (zh) | 用于护理皮肤的套装 | |
CN104130424B (zh) | 一种透明质酸/细菌纤维素复合水凝胶的制备方法 | |
CN113498336A (zh) | 用于皮肤护理的试剂盒 | |
CN107485598B (zh) | 一种自增稠珍珠化妆水及其制备方法 | |
CN102839569A (zh) | 一种壳聚糖湿巾纸及其制备方法 | |
KR20180119282A (ko) | 고체 원물이 포함된 바이오셀룰로오스, 이를 제조하기 위한 배지 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11764873 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11764873 Country of ref document: EP Kind code of ref document: A1 |